Leiomyosarcoma of Ovary

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Leiomyosarcoma of Ovary trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT06749600

Clinical Management and Outcomes of Primary Ovarian Leiomyosarcoma

This observational study aims to gather comprehensive data on primary ovarian leiomyosarcoma (POLMS). This extremely rare malignancy accounts for less than 3% o…

Italy30 participantsStarted 2024-06-14

RecruitingPhase 2

NCT04383119

Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma

Study is aimed at evaluating the activity of Trabectedin (arm A) in advanced leiomyosarcomas, having Gemcitabine (arm B) as the comparator. In addition to the…

Italy100 participantsStarted 2021-10-29

Treatment: Trabectedin, Gemcitabine

All recent trials (3 shown)

CompletedPhase 2

NCT00815945

Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and M…

Uterine sarcomas account for less than 5% of all carcinomas of the uterine corpus. The prognosis of these patients is extremely limited. Recurrence rates of 50-…

Germany41 participantsStarted 2008-06

Treatment: PegLiposomal Doxorubicin, Carboplatin